Litcius/Paper detail

Engineered Bacteria for Enhanced Radiotherapy against Breast Carcinoma

Pei Pan, Xue Dong, Ying Chen, Xuan Zeng, Xian‐Zheng Zhang

2022ACS Nano102 citationsDOI

Abstract

nanoparticles (BNPs) for sensitizing radiotherapy. Bac could target and colonize in tumor sites alternatively, which overexpressed cytolysin A (ClyA) protein to regulate the cell cycle from a radioresistant phase to a radiosensitive phase. Simultaneously, peptide-modified BNPs, as a radiosensitizer with a high-Z element, was released from the surface of Bac owing to the matrix metalloproteinase-2 (MMP-2) response in the tumor microenvironment. Under X-ray irradiation, BNPs could enhance the radiotherapy sensitivity by triggering the intracellular generation of reactive oxygen species (ROS), coupled with DNA damage. In this constructed nanosystem, the combination of Bac@BNP and X-ray irradiation led to significant suppression of breast carcinoma in murine models with reduced side effects.

Topics & Concepts

RadiosensitizerRadioresistanceRadiation therapyCancer researchChemistryMatrix metalloproteinaseDNA damageMedicineDNABiochemistryInternal medicineCancer Research and TreatmentsNanoplatforms for cancer theranosticsRadiation Therapy and Dosimetry
Engineered Bacteria for Enhanced Radiotherapy against Breast Carcinoma | Litcius